News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Visioneering Technologies.
RELATED STOCKHEAD STORIES
Health & Biotech
Health Check: The robots are taking over biotech stock selection
Health & Biotech
ASX Health Stocks: Mesoblast rockets 20pc after being granted Rare Pediatric Disease Designation by FDA
News
Market Highlights: Tech rally on Nasdaq, commodities bounce back, and 5 ASX small caps to watch today
News
Market Highlights: ASX set to rise again, Birkenstock’s disappointing IPO, and 5 ASX small caps to watch today
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: War – Gold – Oil – The ASX – Monday
Tech
ASX Tech September Winners: Sluggish September cures Wall Street’s IPO fever
Health & Biotech
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?
News
Market Highlights: Bank chiefs spook Wall Street, and 5 ASX small caps to watch on Wednesday
Health & Biotech
ASX Health Stocks: Clinical trials gather pace for Visioneering Tech, Anteris and other biotechs
News
Market Highlights and 5 ASX Small Caps to watch on Monday
Experts
Twenty-One of the Best: Tim Boreham’s Hot Stocks for 2022
Health & Biotech
Dr Boreham’s Crucible: Visoneering’s taking the longview on short-sightedness – and it’s starting to pay off
Health & Biotech
China is about to grant patents like never before, and these ASX stocks have already got some
Health & Biotech
ASX Health Stocks: Visioneering jumps 13pc on contact lenses launch, Sigma drops bid for API
News
10 at 10: These ASX stocks are illuminated the most brightly this morning
Health & Biotech
